Show simple item record

dc.contributor.authorBugra, Coskun
dc.contributor.authorBurcin, Salman-Ozgu
dc.contributor.authorBurcu, Kisa
dc.contributor.authorBora, Coskun
dc.contributor.authorFerdi, Kinci Mehmet
dc.contributor.authorEser, Colak
dc.contributor.authorOzlem, Evliyaoglu
dc.date.accessioned2020-07-27T08:34:40Z
dc.date.available2020-07-27T08:34:40Z
dc.date.issued2019
dc.identifier.issn1873-9598en_US
dc.identifier.urihttps://www.airitilibrary.com/Publication/alDetailedMesh?DocID=P20190312001-201912-201912170002-201912170002-335-338
dc.identifier.urihttp://hdl.handle.net/11727/4793
dc.description.abstractBackground: We have aimed to identify the markers for malignant transformation and also determine the differences between the reproductive age and postmenopausal mature cystic teratoma (MCT) patients. Methods: Between 2008 and 2015, totally 246 patients informations diagnosed as MCT have been examined retrospectively. Demographic characteristics of the patients, preoperative examinations, final pathology results have been evaluated. Results: It is included 246 patients with a total of 117 postmenopausal, 129 reproductive age in the study. When demographic characteristics, tumor markers and mass size were compared, only Carcino Embryogenic Antigen (CEA) values were found to be statistically significantly higher in postmenopausal patients. Malignancy was detected in 5 patients (2.03%), all of them were in the postmenopausal period, also CA125 and CA15-3 were determined statistically high in malignant patients. Conclusions: We think that CA125 can be use as marker for MT in MCT as well as on epithelial ovarian tumors. The duration of mass inside the abdomen without being operated can be a risk factor for malignant transformation. Because of this reason even if it is asymptomatic, after MCI diagnose we think that it will be good to operate the patients without losing time for prevention of malignant transformation. Copyright (C) 2019, Taiwan Society of Geriatric Emergency & Critical Care Medicine.en_US
dc.language.isoengen_US
dc.relation.isversionof10.6890/IJGE.201912_13(4).0014en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectadnexial massen_US
dc.subjectdermoid cysten_US
dc.subjecttumor markeren_US
dc.subjectadvanced ageen_US
dc.titleIs Presence Time of Dermoid Cysts a Risk Factor for Malignancy Potential in Advanced Age?en_US
dc.typearticleen_US
dc.relation.journalINTERNATIONAL JOURNAL OF GERONTOLOGYen_US
dc.identifier.volume13en_US
dc.identifier.issue4en_US
dc.identifier.startpage335en_US
dc.identifier.endpage338en_US
dc.identifier.wos000503866900015en_US
dc.identifier.scopus2-s2.0-85077387227en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record